Health
A heart drug aimed at a risk Black patients carry more often failed. Under 4% of its trial was of African ancestry.
Pelacarsen cut Lp(a) by 78% in 8,323 patients and did not prevent a single extra heart attack or stroke
Topic
Sunday, November 8, 2026News that matters to Black communities
Topic
Pelacarsen cut Lp(a) by 78% in 8,323 patients and did not prevent a single extra heart attack or stroke
Get the latest news, free. We'll let you know when a big story breaks. A few a day at most.